company background image
BLR logo

BLIRT WSE:BLR Stock Report

Last Price

zł14.90

Market Cap

zł261.1m

7D

0%

1Y

5.1%

Updated

04 Aug, 2022

Data

Company Financials

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

BLIRT S.A. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for BLIRT
Historical stock prices
Current Share Pricezł14.90
52 Week Highzł15.90
52 Week Lowzł6.20
Beta-1.65
1 Month Change0%
3 Month Change65.56%
1 Year Change5.08%
3 Year Change2,157.58%
5 Year Change1,121.31%
Change since IPO127.48%

Recent News & Updates

Recent updates

Market Cool On BLIRT S.A.'s (WSE:BLR) Earnings Pushing Shares 26% Lower

Oct 02
Market Cool On BLIRT S.A.'s (WSE:BLR) Earnings Pushing Shares 26% Lower

BLIRT S.A. (WSE:BLR) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Oct 02
BLIRT S.A. (WSE:BLR) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny

BLIRT's (WSE:BLR) Earnings Are Of Questionable Quality

May 19
BLIRT's (WSE:BLR) Earnings Are Of Questionable Quality

Will Weakness in BLIRT S.A.'s (WSE:BLR) Stock Prove Temporary Given Strong Fundamentals?

Jan 14
Will Weakness in BLIRT S.A.'s (WSE:BLR) Stock Prove Temporary Given Strong Fundamentals?

With EPS Growth And More, BLIRT (WSE:BLR) Is Interesting

Dec 09
With EPS Growth And More, BLIRT (WSE:BLR) Is Interesting

Shareholder Returns

BLRPL BiotechsPL Market
7D0%0.07%2.3%
1Y5.1%-17.6%35.3%

Return vs Industry: BLR exceeded the Polish Biotechs industry which returned -30.9% over the past year.

Return vs Market: BLR exceeded the Polish Market which returned -23.4% over the past year.

Price Volatility

Is BLR's price volatile compared to industry and market?
BLR volatility
BLR Average Weekly Movementn/a
Biotechs Industry Average Movement4.9%
Market Average Movement5.0%
10% most volatile stocks in PL Market9.5%
10% least volatile stocks in PL Market3.2%

Stable Share Price: BLR's share price has been volatile over the past 3 months.

Volatility Over Time: Insufficient data to determine BLR's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
199475Thierry Bernardhttps://www.blirt.eu

BLIRT S.A. engages in the manufacture and sale of recombinant enzymes for the life science industry. It offers proteins and enzymes, such as proteinases, RNase inhibitors, polymerases, nucleases, ligases, and other proteins; and molecular biology reagents, including DNA and RNA extraction, PCR and real-time PCR, reverse transcriptions, and RNA related products. BLIRT S.A. was founded in 1994 and is headquartered in Gdansk, Poland.

BLIRT S.A. Fundamentals Summary

How do BLIRT's earnings and revenue compare to its market cap?
BLR fundamental statistics
Market capzł261.14m
Earnings (TTM)zł7.57m
Revenue (TTM)zł39.77m

34.5x

P/E Ratio

6.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BLR income statement (TTM)
Revenuezł39.77m
Cost of Revenuezł5.68m
Gross Profitzł34.09m
Other Expenseszł26.52m
Earningszł7.57m

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

Aug 11, 2022

Earnings per share (EPS)0.43
Gross Margin85.72%
Net Profit Margin19.02%
Debt/Equity Ratio0.001%

How did BLR perform over the long term?

See historical performance and comparison

Dividends

6.7%

Current Dividend Yield

232%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.